Supernus Pharmaceuticals (SUPN) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
0.37
0.58
0.79
1.01

Details

Expected EPS
0.59
Actual EPS
1.005394
Surprise EPS
0.42
Surprise Percent
+70.41%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 1.005394 per share for Q4 2025.

0 Comments

Share your thoughts